1887

Abstract

The tree shrew (), a small animal widely distributed in Southeast Asia and southwest China, has the potential to be developed as an animal model for hepatitis C. To determine the susceptibility of the tree shrew to hepatitis C virus (HCV) infection and , a well-established HCV, produced from the J6/JFH1-Huh7.5.1 culture system, was used to infect cultured primary tupaia hepatocytes (PTHs) and tree shrews. The results showed that HCV genomic RNA and HCV-specific nonstructural protein 5A (NS5A) could be detected in the PTH cell culture from days 3–15 post-infection, although the viral load was lower than that observed in Huh7.5.1 cell culture. The occurrence of five sense mutations [S391A, G397A, L402F and M405T in the hypervariable region 1 (HVR1) of envelope glycoprotein 2 and I2750M in NS5B] suggested that HCV undergoes genetic evolution during culture. Fourteen of the 30 experimental tree shrews (46.7 %) were found to be infected, although the HCV viremia was intermittent in . A positive test for HCV RNA in liver tissue provided stronger evidence for HCV infection and replication in tree shrews. The results of an immunohistochemistry assay also demonstrated the presence of four HCV-specific proteins (Core, E2, NS3/4 and NS5A) in the hepatocytes of infected tree shrews. The pathological changes observed in the liver tissue of infected tree shrews could be considered to be representative symptoms of mild hepatitis. These results revealed that the tree shrew can be used as an animal model supporting the infection and replication of HCV and .

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000869
2017-08-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/8/2069.html?itemId=/content/journal/jgv/10.1099/jgv.0.000869&mimeType=html&fmt=ahah

References

  1. Bandiera S, Billie Bian C, Hoshida Y, Baumert TF, Zeisel MB. Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma. Curr Opin Virol 2016; 20:99–105 [View Article][PubMed]
    [Google Scholar]
  2. Esposito I, Trinks J, Soriano V. Hepatitis C virus resistance to the new direct-acting antivirals. Expert Opin Drug Metab Toxicol 2016; 12:1197–1209 [View Article][PubMed]
    [Google Scholar]
  3. Vercauteren K, de Jong YP, Meuleman P. Animal models for the study of HCV. Curr Opin Virol 2015; 13:67–74 [View Article][PubMed]
    [Google Scholar]
  4. Bility MT, Zhang L, Washburn ML, Curtis TA, Kovalev GI et al. Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis. Nat Protoc 2012; 7:1608–1617 [View Article][PubMed]
    [Google Scholar]
  5. Douglas DN, Kneteman NM. Generation of improved mouse models for the study of hepatitis C virus. Eur J Pharmacol 2015; 759:313–325 [View Article][PubMed]
    [Google Scholar]
  6. Tsukiyama-Kohara K, Kohara M. Tupaia belangeri as an experimental animal model for viral infection. Exp Anim 2014; 63:367–374 [View Article][PubMed]
    [Google Scholar]
  7. Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H et al. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J Clin Invest 2002; 109:221–232 [View Article][PubMed]
    [Google Scholar]
  8. Tong Y, Zhu Y, Xia X, Liu Y, Feng Y et al. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection. J Virol 2011; 85:2793–2802 [View Article][PubMed]
    [Google Scholar]
  9. Feng Y, Feng YM, Feng Y, Lu C, Liu L et al. Identification and characterization of liver MicroRNAs of the chinese tree Shrew via Deep sequencing. Hepat Mon 2015; 15:e29053 [View Article][PubMed]
    [Google Scholar]
  10. Xu X, Chen H, Cao X, Ben K. Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma. J Gen Virol 2007; 88:2504–2512 [View Article][PubMed]
    [Google Scholar]
  11. Amako Y, Tsukiyama-Kohara K, Katsume A, Hirata Y, Sekiguchi S et al. Pathogenesis of hepatitis C virus infection in Tupaia belangeri. J Virol 2010; 84:303–311 [View Article][PubMed]
    [Google Scholar]
  12. Lohmann V, Bartenschlager R. On the history of hepatitis C virus cell culture systems. J Med Chem 2014; 57:1627–1642 [View Article][PubMed]
    [Google Scholar]
  13. Lindenbach BD, Evans MJ, Syder AJ, Wölk B, Tellinghuisen TL et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309:623–626 [View Article][PubMed]
    [Google Scholar]
  14. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791–796 [View Article][PubMed]
    [Google Scholar]
  15. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005; 102:9294–9299 [View Article][PubMed]
    [Google Scholar]
  16. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 2006; 103:3805–3809 [View Article][PubMed]
    [Google Scholar]
  17. Barth H, Cerino R, Arcuri M, Hoffmann M, Schürmann P et al. Scavenger receptor class B type I and hepatitis C virus infection of primary Tupaia hepatocytes. J Virol 2005; 79:5774–5785 [View Article][PubMed]
    [Google Scholar]
  18. Darai G, Schwaier A, Komitowski D, Munk K. Experimental infection of Tupaia belangeri (tree shrews) with herpes simplex virus types 1 and 2. J Infect Dis 1978; 137:221–226 [View Article][PubMed]
    [Google Scholar]
  19. Fan Y, Huang ZY, Cao CC, Chen CS, Chen YX et al. Genome of the Chinese tree shrew. Nat Commun 2013; 4:1426 [View Article][PubMed]
    [Google Scholar]
  20. Xu L, Yu D, Fan Y, Peng L, Wu Y et al. Loss of RIG-I leads to a functional replacement with MDA5 in the Chinese tree shrew. Proc Natl Acad Sci USA 2016; 113:10950–10955 [View Article][PubMed]
    [Google Scholar]
  21. Xie ZC, Riezu-Boj JI, Lasarte JJ, Guillen J, Su JH et al. Transmission of hepatitis C virus infection to tree shrews. Virology 1998; 244:513–520 [View Article][PubMed]
    [Google Scholar]
  22. Hayashi J, Furusyo N, Ariyama I, Sawayama Y, Etoh Y et al. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia. J Infect Dis 2000; 181:1523–1527 [View Article][PubMed]
    [Google Scholar]
  23. Shiha GE, Zalata KR, Abdalla AF, Mohamed MK. Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining patterns. Liver Int 2005; 25:254–260 [View Article][PubMed]
    [Google Scholar]
  24. Castell JV, Gómez-Lechón MJ. Liver cell culture techniques. Methods Mol Biol 2009; 481:35–46 [View Article][PubMed]
    [Google Scholar]
  25. Urban S, Bartenschlager R, Kubitz R, Zoulim F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology 2014; 147:48–64 [View Article][PubMed]
    [Google Scholar]
  26. Guitart A, Riezu-Boj JI, Elizalde E, Larrea E, Berasain C et al. Hepatitis C virus infection of primary Tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-κB nuclear translocation. J Gen Virol 2005; 86:3065–3074 [View Article][PubMed]
    [Google Scholar]
  27. Lu L, Tatsunori N, Li C, Waheed S, Gao F et al. HCV selection and HVR1 evolution in a chimpanzee chronically infected with HCV-1 over 12 years. Hepatol Res 2008; 38:704–716 [View Article][PubMed]
    [Google Scholar]
  28. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S et al. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175:220–228 [View Article][PubMed]
    [Google Scholar]
  29. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the Flavivirus envelope and NS1 proteins and the Pestivirus envelope glycoproteins. Virology 1991; 180:842–848 [View Article][PubMed]
    [Google Scholar]
  30. Lou H, Choi YH, Lavoy JE, Major ME, Hagedorn CH. Analysis of mutant NS5B proteins encoded by isolates from chimpanzees chronically infected following clonal HCV RNA inoculation. Virology 2003; 317:65–72 [View Article][PubMed]
    [Google Scholar]
  31. Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM et al. Transmission of Hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997; 277:570–574 [View Article][PubMed]
    [Google Scholar]
  32. Major ME, Mihalik K, Fernandez J, Seidman J, Kleiner D et al. Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol 1999; 73:3317–3325[PubMed]
    [Google Scholar]
  33. Lee SM, Schelcher C, Demmel M, Hauner M, Thasler WE. Isolation of human hepatocytes by a two-step collagenase perfusion procedure. J Vis Exp 2013;; 3:50615 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000869
Loading
/content/journal/jgv/10.1099/jgv.0.000869
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error